← FDA Drug Approvals (Drugs@FDA)

NUPLAZID

NDA · New Drug Application · Sponsor: ACADIA PHARMS INC · Approved 2018-06-28

Drug application

FDA Application #
NDA210793
Application type
New Drug Application
Brand name
NUPLAZID
Generic name
PIMAVANSERIN TARTRATE
Active ingredients
PIMAVANSERIN TARTRATE
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
ACADIA PHARMS INC
Manufacturer
Acadia Pharmaceuticals Inc.
First approval
2018-06-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown